Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CH.1.1.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.109NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FR.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCZNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FR.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCDNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.44.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.45.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FP.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.102NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.13.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCCNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.21.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FP.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.92NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.42NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.35.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.4.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.8.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.45NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDRNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.43.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used